a(CHEBI:eptifibatide) causesNoChange a(HM:schistocytosis)

View Subject View Object

PubMed:29956069

Interestingly, inhibition of coagulation is capable of diminishing DIC and hemolysis but not antiplatelet therapy—treatment with eptifibatide (an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class) failed to reduce LPS-induced DIC, schistocyte formation, and hemolysis.

Related Edges 2

• a(CHEBI:eptifibatide) causesNoChange path(MESH:"Disseminated Intravascular Coagulation")
• a(CHEBI:eptifibatide) causesNoChange path(MESH:Hemolysis)

Cell Ontology (CL)

erythrocyte

MeSH

Microvessels

MeSH

Disseminated Intravascular Coagulation

Text Location

Review

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.

---